Treatment advances in neonatal neuroprotection and neurointensive care

The Lancet Neurology

Volumn 10, Issue 4, 2011, Pages 372-382

  Johnston, Michael V ^a   Fatemi, Ali ^a   Wilson, Mary Ann ^a   Northington, Frances ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

7 NITROINDAZOLE; ACETYLCYSTEINE; ALLOPURINOL; ANTICONVULSIVE AGENT; ANTIOXIDANT; ASCORBIC ACID; BRAIN DERIVED NEUROTROPHIC FACTOR; BUMETANIDE; CATALASE; CROMOGLYCATE DISODIUM; DIZOCILPINE; ERYTHROPOIETIN; ETIRACETAM; GLUTATHIONE; GLUTATHIONE PEROXIDASE; INDOMETACIN; MAGNESIUM SULFATE; MELATONIN; MEMANTINE; MINOCYCLINE; N METHYL DEXTRO ASPARTIC ACID; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; NERVE GROWTH FACTOR; NEUROPROTECTIVE AGENT; PHENOBARBITAL; SOMATOMEDIN C; SUPEROXIDE DISMUTASE; TOPIRAMATE; UNINDEXED DRUG; XENON;

ANTICONVULSANT THERAPY; ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; APGAR SCORE; BRAIN DISEASE; BRAIN HYPOXIA; BRAIN INJURY; BRAIN ISCHEMIA; CEREBRAL PALSY; COOLING; DIFFERENTIAL DIAGNOSIS; DISABILITY; DISEASE SEVERITY; ELECTROENCEPHALOGRAPHY; HANDICAPPED CHILD; HISTOLOGY; HUMAN; HYPOTHERMIA; HYPOXIC ISCHEMIC ENCEPHALOPATHY; INFLAMMATION; META ANALYSIS (TOPIC); NEUROPATHOLOGY; NEUROPROTECTION; NEWBORN; NEWBORN HYPOXIA; NEWBORN INTENSIVE CARE; NEWBORN MORTALITY; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; OXIDATIVE STRESS; PATHOGENESIS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; RISK REDUCTION; SEIZURE; SEX DIFFERENCE; SURVIVAL RATE; TOTAL BODY HYPOTHERMIA; TREATMENT OUTCOME;

CLINICAL TRIALS AS TOPIC; HUMANS; HYPOTHERMIA, INDUCED; HYPOXIA-ISCHEMIA, BRAIN; INFANT, NEWBORN; PROGNOSIS; TREATMENT OUTCOME;

EID: 79952722818     PISSN: 14744422     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1474-4422(11)70016-3     Document Type: Review

References (155)

1. Kurinczuk JJ, White-Koning M, Badawi N Epidemiology of neonatal encephalopathy and hypoxic-ischaemic encephalopathy. Early Hum Dev 2010, 86:329-338.
2. Ellis M, Manandhar DS, Manandhar N, Wyatt J, Bolam AJ, Costello AM Stillbirths and neonatal encephalopathy in Kathmandu, Nepal: an estimate of the contribution of birth asphyxia to perinatal mortality in a low-income urban population. Paediatr Perinat Epidemiol 2000, 14:39-52.
3. Lawn JE, Cousens S, Zupan J 4 million neonatal deaths: when? Where? Why?. Lancet 2005, 365:891-900.
4. Nelson KB, Lynch JK Stroke in newborn infants. Lancet Neurol 2006, 3:150-158.
5. Sherlock RL, McQuillen PS, Miller SP Preventing brain injury in newborns with congenital heart disease: brain imaging and innovative trial designs. Stroke 2009, 40:327-332.
6. Volpe JJ Brain injury in premature infants: a complex amalgam of destructive and developmental disturbances. Lancet Neurol 2009, 8:110-124.
7. Enns GM Neurologic damage and neurocognitive dysfunction in urea cycle disorders. Semin Pediatr Neurol 2008, 15:132-139.
8. Edwards AD, Brocklehurst P, Gunn AJ, et al. Neurological outcomes at 18 months of age after moderate hypothermia for perinatal hypoxic ischaemic encephalopathy: synthesis and meta-analysis of trial data. BMJ 2010, 340:c363.
9. Hellstrom-Westas L, Rosen I, Svenningsen NW Predictive value of early continuous amplitude integrated EEG recordings on outcome after severe birth asphyxia in full term infants. Arch Dis Child Fetal Neonatal Ed 1995, 72:F34-F38.
10. Thoresen M, Hellstrom-Westas L, Liu X, De Vries LS Effect of hypothermia on amplitude-integrated electroencephalogram in infants with asphyxia. Pediatrics 2010, 126:e131-e139.
11. Fatemi A, Wilson MA, Johnston MV Hypoxic-ischemic encephalopathy in the term infant. Clin Perinatol 2009, 36:835-858.
12. du Plessis AJ, Volpe JJ Perinatal brain injury in the preterm and term newborn. Curr Opin Neurol 2002, 15:151-157.
13. Johnston MV, Nakajima W, Hagberg H Mechanisms of hypoxic neurodegeneration in the developing brain. Neuroscientist 2002, 8:212-220.
14. Cilio MR, Ferriero DM Synergistic neuroprotective therapies with hypothermia. Semin Fetal Neonatal Med 2010, 15:293-298.
15. Sarnat HB, Sarnat MS Neonatal encephalopathy following fetal distress. A clinical and electroencephalographic study. Arch Neurol 1976, 33:696-705.
16. Levene MI, Sands C, Grindulis H, Moore JR Comparison of two methods of predicting outcome in perinatal asphyxia. Lancet 1986, 1:67-69.
17. Badawi N, Kurinczuk JJ, Keogh JM, et al. Intrapartum risk factors for newborn encephalopathy: the Western Australian case-control study. BMJ 1998, 317:1537-1538.
18. Badawi N, Kurinczuk JJ, Keogh JM, et al. Antepartum risk factors for newborn encephalopathy: the Western Australian case-control study. BMJ 1998, 317:1549-1553.
19. Felix JF, Badawi N, Kurinczuk JJ, Bower C, Keogh JM, Pemberton PJ Birth defects in children with newborn encephalopathy. Dev Med Child Neurol 2000, 42:803-808.
20. McDonald JW, Silverstein FS, Johnston MV MK-801 protects the neonatal brain from hypoxic-ischemic damage. Eur J Pharmacol 1987, 140:359-361.
21. Vannucci RC, Towfighi J, Vannucci SJ Secondary energy failure after cerebral hypoxia-ischemia in the immature rat. J Cereb Blood Flow Metab 2004, 24:1090-1097.
22. Hagberg H Mitochondrial impairment in the developing brain after hypoxia-ischemia. J Bioenerg Biomembr 2004, 36:369-373.
23. Hope PL, Costello AM, Cady EB, et al. Cerebral energy metabolism studied with phosphorus NMR spectroscopy in normal and birth-asphyxiated infants. Lancet 1984, 2:366-370.
24. Hope PL, Reynolds EO Investigation of cerebral energy metabolism in newborn infants by phosphorus nuclear magnetic resonance spectroscopy. Clin Perinatol 1985, 12:261-275.
25. Azzopardi D, Wyatt JS, Cady EB, et al. Prognosis of newborn infants with hypoxic-ischemic brain injury assessed by phosphorus magnetic resonance spectroscopy. Pediatr Res 1989, 25:445-451.
26. Wyatt JS, Edwards AD, Azzopardi D, Reynolds EO Magnetic resonance and near infrared spectroscopy for investigation of perinatal hypoxic-ischaemic brain injury. Arch Dis Child 1989, 64:953-963.
27. Lorek A, Takei Y, Cady EB, et al. Delayed (" secondary" ) cerebral energy failure after acute hypoxia-ischemia in the newborn piglet: continuous 48-hour studies by phosphorus magnetic resonance spectroscopy. Pediatr Res 1994, 36:699-706.
28. Blumberg RM, Cady EB, Wigglesworth JS, McKenzie JE, Edwards AD Relation between delayed impairment of cerebral energy metabolism and infarction following transient focal hypoxia-ischaemia in the developing brain. Exp Brain Res 1997, 113:130-137.
29. Tan WK, Williams CE, During MJ, et al. Accumulation of cytotoxins during the development of seizures and edema after hypoxic-ischemic injury in late gestation fetal sheep. Pediatr Res 1996, 39:791-797.
30. Thoresen M Cooling the newborn after asphyxia-physiological and experimental background and its clinical use. Semin Neonatol 2000, 5:61-73.
31. Ferriero DM Neonatal brain injury. N Engl J Med 2004, 351:1985-1995.
32. Johnston MV Excitotoxicity in perinatal brain injury. Brain Pathol 2005, 15:234-240.
33. Johnston MV, Trescher WH, Ishida A, Nakajima W Neurobiology of hypoxic-ischemic injury in the developing brain. Pediatric Res 2001, 49:735-741.
34. Hagberg H, Mallard C, Rousset CI, Xiaoyang W Apoptotic mechanisms in the immature brain: involvement of mitochondria. J Child Neurol 2009, 24:1141-1146.
35. Taylor DL, Edwards AD, Mehmet H Oxidative metabolism, apoptosis and perinatal brain injury. Brain Pathol 1999, 9:93-117.
36. Silverstein FS, Buchanan K, Johnston MV Perinatal hypoxia-ischemia disrupts striatal high-affinity [3H]glutamate uptake into synaptosomes. J Neurochem 1986, 47:1614-1619.
37. Bak LK, Schousboe A, Sonnewald U, Waagepetersen HS Glucose is necessary to maintain neurotransmitter homeostasis during synaptic activity in cultured glutamatergic neurons. J Cereb Blood Flow Metab 2006, 26:1285-1297.
38. Hagberg H, Thornberg E, Blennow M, et al. Excitatory amino acids in the cerebrospinal fluid of asphyxiated infants: relationship to hypoxic-ischemic encephalopathy. Acta Paediatr 1993, 82:925-929.
39. Riikonen RS, Kero PO, Simell OG Excitatory amino acids in cerebrospinal fluid in neonatal asphyxia. Pediatr Neurol 1992, 8:37-40.
40. Hagberg H, Andersson P, Kjellmer I, Thiringer K, Thordstein M Extracellular overflow of glutamate, aspartate, GABA and taurine in the cortex and basal ganglia of fetal lambs during hypoxia-ischemia. Neurosci Lett 1987, 78:311-317.
41. Cross JL, Meloni BP, Bakker AJ, Lee S, Knuckey NW Modes of calcium entry and homeostasis following cerebral ischemia. Stroke Res Treat 2010, published online Nov 1. 10.4061/2010/316862.
42. Takahashi T, Otsuguro K, Ohta T, Ito S Adenosine and inosine release during hypoxia in the isolated spinal cord of neonatal rats. Br J Pharmacol 2010, 161:1806-1816.
43. Cetinkaya M, Alkan T, Ozyener F, Kafa IM, Kurt MA, Koksal N Possible neuroprotective effects of magnesium sulfate and melatonin as both pre- and post-treatment in a neonatal hypoxic-ischemic rat model. Neonatology 2010, 99:302-310.
44. Jensen FE The role of glutamate receptor maturation in perinatal seizures and brain injury. Int J Dev Neurosci 2002, 20:339-347.
45. McDonald JW, Johnston MV Physiological and pathophysiological roles of excitatory amino acids during central nervous system development. Brain Res Rev 1990, 15:41-70.
46. Monyer H, Brunashev N, Laurie DJ Development and regional expression in the rat brain and functional properties of four NMDA receptors. Neuron 1993, 12:529-540.
47. Dzhala VI, Kuchibhotla KV, Glykys JC, et al. Progressive NKCC1-dependent neuronal chloride accumulation during neonatal seizures. J Neurosci 2010, 30:11745-11761.
48. Kahle KT, Staley K Altered neuronal chloride homeostasis and excitatory GABAergic signaling in human temporal lobe epilepsy. Epilepsy Curr 2008, 8:51-53.
49. Blomgren K, Hagberg H Free radicals, mitochondria, and hypoxia-ischemia in the developing brain. Free Radic Biol Med 2006, 40:388-397.
50. Robertson CL, Scafidi S, McKenna MC, Fiskum G Mitochondrial mechanisms of cell death and neuroprotection in pediatric ischemic and traumatic brain injury. Exp Neurol 2009, 218:371-380.
51. Wang X, Han W, Du X, et al. Neuroprotective effect of Bax-inhibiting peptide on neonatal brain injury. Stroke 2010, 41:2050-2055.
52. Han B, Wang Q, Cui G, Shen X, Zhu Z Post-treatment of Bax-inhibiting peptide reduces neuronal death and behavioral deficits following global cerebral ischemia. Neurochem Int 2011, 58:224-233.
53. Blomgren K, Zhu C, Hallin U, Hagberg H Mitochondria and ischemic reperfusion damage in the adult and in the developing brain. Biochem Biophys Res Commun 2003, 304:551-559.
54. Hagberg H Mitochondrial impairment in the developing brain after hypoxia-ischemia. J Bioenerg Biomembr 2004, 36:369-373.
55. Cregan SP, Dawson VL, Slack RS Role of AIF in caspase-dependent and caspase-independent cell death. Oncogene 2004, 23:2785-2796.
56. Blomgren K, Zhu C, Wang X, Karlsson JO, et al. Synergistic activation of caspase-3 by m-calpain after neonatal hypoxia-ischemia: a mechanism of " pathological apoptosis" ?. J Biol Chem 2001, 276:10191-10198.
57. Graham EM, Sheldon RA, Flock DL, et al. Neonatal mice lacking functional Fas death receptors are resistant to hypoxic-ischemic brain injury. Neurobiol Dis 2004, 17:89-98.
58. Gonzalez FF, Ferriero DM Neuroprotection in the newborn infant. Clin Perinatol 2009, 36:859-880.
59. West T, Stump M, Lodygensky G, Neil JJ, Deshmukh M, Holtzman DM Lack of X-linked inhibitor of apoptosis protein leads to increased apoptosis and tissue loss following neonatal brain injury. ASN Neuro 2009, 1:e00004.
60. Zhu C, Xu F, Fukuda A, et al. X chromosome-linked inhibitor of apoptosis protein reduces oxidative stress after cerebral irradiation or hypoxia-ischemia through up-regulation of mitochondrial antioxidants. Eur J Neurosci; 26: 3402-10.
61. Tsuru-Aoyagi K, Potts MB, Trivedi A, et al. Glutathione peroxidase activity modulates recovery in the injured immature brain. Ann Neurol 2009, 65:540-549.
62. Ishida A, Trescher WH, Lange MS, Johnston MV Prolonged suppression of brain nitric oxide synthase activity by 7-nitroindazole protects against cerebral hypoxic-ischemic injury in neonatal rat. Brain Dev 2001, 23:349-354.
63. West T, Atzeva M, Holtzman DM Pomegranate polyphenols and resveratrol protect the neonatal brain against hypoxic-ischemic injury. Dev Neurosci 2007, 29:363-372.
64. Northington FJ, Chavez-Valdez R, Graham EM, Razdan S, Gauda EB, Martin LJ Necrostatin decreases oxidative damage, inflammation, and injury after neonatal HI. J Cereb Blood Flow Metab 2010, 31:178-189.
65. Gressens P, Schwendimann L, Husson I, et al. Agomelatine, a melatonin receptor agonist with 5-HT(2C) receptor antagonist properties, protects the developing murine white matter against excitotoxicity. Eur J Pharmacol 2008, 588:58-63.
66. Wang X, Stridh L, Li W, et al. Lipopolysaccharide sensitizes neonatal hypoxic-ischemic brain injury in a MyD88-dependent manner. J Immunol 2009, 183:7471-7477.
67. Wang X, Svedin P, Nie C, et al. N-acetylcysteine reduces lipopolysaccharide-sensitized hypoxic-ischemic brain injury. Ann Neurol 2007, 61:263-271.
68. Nijboer CH, Heijnen CJ, Groenendaal F, May MJ, van Bel F, Kavelaars A Strong neuroprotection by inhibition of NF-kappaB after neonatal hypoxia-ischemia involves apoptotic mechanisms but is independent of cytokines. Stroke 2008, 39:2129-2137.
69. Jin Y, Silverman AJ, Vannucci SJ Mast cells are early responders after hypoxia-ischemia in immature rat brain. Stroke 2009, 40:3107-3112.
70. Patkai J, Mesples B, Dommergues MA, et al. Deleterious effects of IL-9-activated mast cells and neuroprotection by antihistamine drugs in the developing mouse brain. Pediatr Res 2001, 50:222-230.
71. Russell JC, Kishimoto K, O'Driscoll C, Hossain MA Neuronal pentraxin 1 induction in hypoxic-ischemic neuronal death is regulated via a glycogen synthase kinase-3alpha/beta dependent mechanism. Cell Signal 2010, 23:673-682.
72. Nakajima W, Ishida A, Lange MS, et al. Apoptosis has a prolonged role in the neurodegeneration after hypoxic ischemia in the newborn rat. J Neurosci 2000, 20:7994-8004.
73. Edwards AD, Mehmet H Apoptosis in perinatal hypoxic-ischaemic cerebral damage. Neuropathol Appl Neurobiol 1996, 22:494-498.
74. Northington FJ, Ferriero DM, Flock DL, Martin LJ Delayed neurodegeneration in neonatal rat thalamus after hypoxia-ischemia is apoptosis. J Neurosci 2001, 21:1931-1938.
75. Northington FJ, Graham EM, Martin LJ Apoptosis in perinatal hypoxic-ischemic brain injury: how important is it and should it be inhibited?. Brain Res Brain Res Rev 2005, 50:244-257.
76. Northington FJ, Zelaya ME, O'Riordan DP, et al. Failure to complete apoptosis following neonatal hypoxia-ischemia manifests as " continuum" phenotype of cell death and occurs with multiple manifestations of mitochondrial dysfunction in rodent forebrain. Neuroscience 2007, 149:822-833.
77. Lay CC, Davis MF, Chen-Bee CH, Frostig RD Mild sensory stimulation completely protects the adult rodent cortex from ischemic stroke. PLoS One 2010, 5:e11270.
78. Hagberg H, Wilson MA, Matsushita H, et al. PARP-1 gene disruption in mice preferentially protects males from perinatal brain injury. J Neurochem 2004, 90:1068-1075.
79. McCullough LD, Zeng Z, Blizzard KK, Debchoudhury I, Hurn PD Ischemic nitric oxide and poly (ADP-ribose) polymerase-1 in cerebral ischemia: male toxicity, female protection. J Cereb Blood Flow Metab 2005, 25:502-512.
80. Du L, Bayir H, Lai Y, et al. Innate gender-based proclivity in response to cytotoxicity and programmed cell death pathway. J Biol Chem 2004, 279:38563-38570.
81. Yuan M, Siegel C, Zeng Z, Li J, Liu F, McCullough LD Sex differences in the response to activation of the poly (ADP-ribose) polymerase pathway after experimental stroke. Exp Neurol 2009, 217:210-218.
82. Du L, Hickey RW, Bayir H, et al. Starving neurons show sex difference in autophagy. J Biol Chem 2009, 84:2383-2396.
83. Li H, Pin S, Zeng Z, Wang MM, Andreasson KA, McCullough LD Sex differences in cell death. Ann Neurol 2005, 58:317-321.
84. Renolleau S, Fau S, Goyenvalle C, et al. Specific caspase inhibitor Q-VD-OPh prevents neonatal stroke in P7 rat: a role for gender. J Neurochem 2007, 100:1062-1071.
85. Nijboer CH, Groenendaal F, Kavelaars A, Hagberg HH, van Bel F, Heijnen CJ Gender-specific neuroprotection by 2-iminobiotin after hypoxia-ischemia in the neonatal rat via a nitric oxide independent pathway. J Cereb Blood Flow Metab 2007, 27:282-292.
86. Comi AM, Highet BH, Mehta P, Hana CT, Johnston MV, Wilson MA Dextromethorphan protects male but not female mice with brain ischemia. Neuroreport 2006, 17:1319-1322.
87. Wen TC, Rogido M, Peng H, Genetta T, Moore J, Sola A Gender differences in long-term beneficial effects of erythropoietin given after neonatal stroke in postnatal day-7 rats. Neuroscience 2006, 139:803-811.
88. Fan X, Heijnen CJ, van der Kooij MA, Groenendaal F, van Bel F Beneficial effect of erythropoietin on sensorimotor function and white matter after hypoxia-ischemia in neonatal mice. Pediatr Res 2011, 69:56-61.
89. West T, Atzeva M, Holtzman DM Caspase-3 deficiency during development increases vulnerability to hypoxic-ischemic injury through caspase-3-independent pathways. Neurobiol Dis 2006, 22:523-537.
90. Golomb MR, Fullerton HJ, Nowak-Gottl U, deVeber G Male predominance in childhood ischemic stroke: findings from the international pediatric stroke study. Stroke 2009, 40:52-57.
91. Johnston MV, Hagberg H Sex and the pathogenesis of cerebral palsy. Dev Med Child Neurol 2007, 49:74-78.
92. Cowan F, Rutherford M, Groenendaal F, et al. Origin and timing of brain lesions in term infants with neonatal encephalopathy. Lancet 2003, 361:736-742.
93. Menkes JH, Curran J Clinical and MR correlates in children with extrapyramidal cerebral palsy. AJNR Am J Neuroradiol 1994, 15:451-457.
94. Barkovich AJ, Westmark K, Partridge C, Sola A, Ferriero DM Perinatal asphyxia: MR findings in the first 10 days. AJNR Am J Neuroradiol 1995, 16:427-438.
95. Maller AI, Hankins LL, Yeakley JW, Butler IJ Rolandic type cerebral palsy in children as as a pattern of hypoxic-ischemic injury in the full term neonate. J Child Neurol 1998, 13:313-321.
96. Ferrari F, Todeschini A, Guidotti I, et al. General movements in full-term infants with perinatal asphyxia are related to basal ganglia and thalamic lesions. J Pediatr 2011, published online Jan 14. 10.1016/j.jpeds.2010.11.037.
97. Johnston MV, Hoon AH Possible mechanisms in infants for selective basal ganglia damage from asphyxia, kernicterus, or mitochondrial encephalopathies. J Child Neurol 2000, 15:588-591.
98. Barkovich AJ MR imaging of the neonatal brain. Neuroimaging Clin N Am 2006, 16:117-135.
99. Hoon AH, Reinhardt EM, Kelley RI, et al. Brain magnetic resonance imaging in suspected extrapyramidal cerebral palsy: observations in distinguishing genetic-metabolic from acquired causes. J Pediatr 1997, 131:240-245.
100. Mueller-Burke D, Koehler RC, Martin LJ Rapid NMDA receptor phosphorylation and oxidative stress precede striatal neurodegeneration after hypoxic ischemia in newborn piglets and are attenuated with hypothermia. Int J Dev Neurosci 2008, 26:67-76.
101. Stone BS, Zhang J, Mack DW, Mori S, Martin LJ, Northington FJ Delayed neural network degeneration after neonatal hypoxia-ischemia. Ann Neurol 2008, 64:535-546.
102. Fuller S, Rajagopalan R, Jarvik GP, et al. J. Maxwell Chamberlain Memorial Paper for congenital heart surgery. Deep hypothermic circulatory arrest does not impair neurodevelopmental outcome in school-age children after infant cardiac surgery. Ann Thorac Surg 2010, 90:1985-1994.
103. Gunn AJ, Bennet L Brain cooling for preterm infants. Clin Perinatol 2008, 35:735-748.
104. Thoresen M, Penrice J, Lorek A, et al. Mild hypothermia after severe transient hypoxia-ischemia ameliorates delayed cerebral energy failure in the newborn piglet. Pediatr Res 1995, 37:667-670.
105. Thoresen M, Satas S, Puka-Sundvall M, et al. Post-hypoxic hypothermia reduces cerebrocortical release of NO and excitotoxins. Neuroreport 1997, 8:3359-3362.
106. Amess PN, Penrice J, Cady EB, et al. Mild hypothermia after severe transient hypoxia-ischemia reduces the delayed rise in cerebral lactate in the newborn piglet. Pediatr Res 1997, 41:803-808.
107. Bennet L, Dean JM, Wassink G, Gunn AJ Differential effects of hypothermia on early and late epileptiform events after severe hypoxia in preterm fetal sheep. J Neurophysiol 2007, 97:572-578.
108. Drury PP, Bennet L, Gunn AJ Mechanisms of hypothermic neuroprotection. Semin Fetal Neonatal Med 2010, 15:287-292.
109. McDonald JW, Chen CK, Trescher WH, Johnston MV The severity of excitotoxic brain injury is dependent on brain temperature in immature rat. Neurosci Lett 1991, 126:83-86.
110. Ikonomidou C, Mosinger JL, Olney JW Hypothermia enhances protective effect of MK-801 against hypoxic/ischemic brain damage in infant rats. Brain Res 1989, 487:184-187.
111. Trescher WH, Ishiwa S, Johnston MV Brief post-hypoxic-ischemic hypothermia markedly delays neonatal brain injury. Brain Dev 1997, 19:326-338.
112. Gluckman PD, Wyatt JS, Azzopardi D, et al. Selective head cooling with mild systemic hypothermia after neonatal encephalopathy: multicentre randomised trial. Lancet 2005, 365:663-670.
113. Shankaran S, Laptook AR, Ehrenkranz RA, et al. Whole-body hypothermia for neonates with hypoxic-ischemic encephalopathy. N Engl J Med 2005, 353:1574-1584.
114. Azzopardi DV, Strohm B, Edwards AD, et al. Moderate hypothermia to treat perinatal asphyxial encephalopathy. N Engl J Med 2009, 361:1349-1358.
115. Shellhaas RA, Gallagher PR, Clancy RR Assessment of neonatal electroencephalography (EEG) background by conventional and two amplitude-integrated EEG classification systems. J Pediatr 2008, 153:369-374.
116. Shah DK, Mackay MT, Lavery S, et al. Accuracy of bedside electroencephalographic monitoring in comparison with simultaneous continuous conventional electroencephalography for seizure detection in term infants. Pediatrics 2008, 121:1146-1154.
117. Frenkel N, Friger M, Meledin I, et al. Neonatal seizure recognition-Comparative study of continuous-amplitude integrated EEG versus short conventional EEG recordings. Clin Neurophysiol 2011, published online Jan 7. 10.1016/j.clinph.2010.09.028.
118. Shah PS Hypothermia: a systematic review and meta-analysis of clinical trials. Semin Fetal Neonatal Med 2010, 15:238-246.
119. Eicher DJ, Wagner CL, Katikaneni LP, et al. Moderate hypothermia in neonatal encephalopathy: safety outcomes. Pediatr Neurol 2005, 32:18-24.
120. Eicher DJ, Wagner CL, Katikaneni LP, et al. Moderate hypothermia in neonatal encephalopathy: efficacy outcomes. Pediatr Neurol 2005, 32:11-17.
121. Jacobs S, Hunt R, Tarnow-Mordi W, Inder T, Davis P Cooling for newborns with hypoxic ischaemic encephalopathy. Cochrane Database Syst Rev 2003, 4. CD003311.
122. Simbruner G, Mittal RA, Rohlmann F, Muche R Systemic hypothermia after neonatal encephalopathy: outcomes of neo.nEURO.network RCT. Pediatrics 2010, 126:e771-e778.
123. Barks JD, Liu YQ, Shangguan Y, Silverstein FS Phenobarbital augments hypothermic neuroprotection. Pediatr Res 2010, 67:532-537.
124. Filippi L, Poggi C, la Marca G, et al. Oral topiramate in neonates with hypoxic ischemic encephalopathy treated with hypothermia: a safety study. J Pediatr 2010, 157:361-366.
125. Liu C, Lin N, Wu B, Qiu Y Neuroprotective effect of memantine combined with topiramate in hypoxic-ischemic brain injury. Brain Res 2009, 1282:173-182.
126. Chakkarapani E, Dingley J, Liu X, et al. Xenon enhances hypothermic neuroprotection in asphyxiated newborn pigs. Ann Neurol 2010, 68:330-341.
127. Dzhala VI, Kuchibhotla KV, Glykys JC, et al. Progressive NKCC1-dependent neuronal chloride accumulation during neonatal seizures. J Neurosci 2010, 30:11745-11761.
128. Fox C, Dingman A, Derugin N, et al. Minocycline confers early but transient protection in the immature brain following focal cerebral ischemia-reperfusion. J Cereb Blood Flow Metab 2005, 25:1138-1149.
129. Tsuji M, Wilson MA, Lange MS, Johnston MV Minocycline worsens hypoxic-ischemic brain injury in a neonatal mouse model. Exp Neurol 2004, 189:58-65.
130. Fan X, van BF Pharmacological neuroprotection after perinatal asphyxia. J Matern Fetal Neonatal Med 2010, 23(suppl 3):17-19.
131. Kelen D, Robertson NJ Experimental treatments for hypoxic ischaemic encephalopathy. Early Hum Dev 2010, 86:369-377.
132. Kaandorp JJ, Benders MJ, Rademaker CM, et al. Antenatal allopurinol for reduction of birth asphyxia induced brain damage (ALLO-Trial); a randomized double blind placebo controlled multicenter study. BMC Pregnancy Childbirth 2010, 10:8.
133. Chaudhari T, McGuire W Allopurinol for preventing mortality and morbidity in newborn infants with suspected hypoxic-ischaemic encephalopathy. Cochrane Database Syst Rev 2008, 2. CD006817.
134. Clancy RR Neuroprotection in infant heart surgery. Clin Perinatol 2008, 35:809-821.
135. Ishida A, Trescher WH, Lange MS, Johnston MV Prolonged suppression of brain nitric oxide synthase activity by 7-nitroindazole protects against cerebral hypoxic-ischemic injury in neonatal rat. Brain Dev 2001, 23:349-354.
136. Matsushita H, Johnston MV, Lange MS, Wilson MA Protective effect of erythropoietin in neonatal hypoxic ischemia in mice. Neuroreport 2003, 14:1757-1761.
137. Elmahdy H, El-Mashad AR, El-Bahrawy H, El-Gohary T, El-Barbary A, Aly H Human recombinant erythropoietin in asphyxia neonatorum: pilot trial. Pediatrics 2010, 125:e1135-e1142.
138. McPherson RJ, Juul SE Erythropoietin for infants with hypoxic-ischemic encephalopathy. Curr Opin Pediatr 2010, 22:139-145.
139. Zhu C, Kang W, Xu F, et al. Erythropoietin improved neurologic outcomes in newborns with hypoxic-ischemic encephalopathy. Pediatrics 2009, 124:e218-e226.
140. Holtzman DM, Sheldon RA, Jaffe W, Cheng Y, Ferriero DM Nerve growth factor protects the neonatal brain against hypoxic-ischemic injury. Ann Neurol 1996, 39:114-122.
141. Zhong J, Zhao L, Du Y, et al. Delayed IGF-1 treatment reduced long-term hypoxia-ischemia-induced brain damage and improved behavior recovery of immature rats. Neurol Res 2009, 31:483-489.
142. Beresewicz M, Majewska M, Makarewicz D, Vayro S, Zablocka B, Gorecki DC Changes in the expression of insulin-like growth factor 1 variants in the postnatal brain development and in neonatal hypoxia-ischaemia. Int J Dev Neurosci 2010, 28:91-97.
143. Gluckman P, Klempt N, Guan J, et al. A role for IGF-1 in the rescue of CNS neurons following hypoxic-ischemic injury. Biochem Biophys Res Commun 1992, 182:593-599.
144. Han BH, Holtzman DM BDNF protects the neonatal brain from hypoxic-ischemic injury in vivo via the ERK pathway. J Neurosci 2000, 20:5775-5781.
145. Meyn DF, Ness J, Ambalavanan N, Carlo WA Prophylactic phenobarbital and whole-body cooling for neonatal hypoxic-ischemic encephalopathy. J Pediatr 2010, 157:334-336.
146. Silverstein FS, Ferriero DM Off-label use of antiepileptic drugs for the treatment of neonatal seizures. Pediatr Neurol 2008, 39:77-79.
147. Liu Y, Barks JD, Xu G, Silverstein FS Topiramate extends the therapeutic window for hypothermia-mediated neuroprotection after stroke in neonatal rats. Stroke 2004, 35:1460-1465.
148. Gathwala G, Marwah A, Gahlaut V, Marwah P Effect of high-dose phenobarbital on oxidative stress in perinatal asphyxia: an open label randomized controlled trial. Indian Pediatr 2010, published online Nov 30. PII:S097475590900675-1.
149. Dickinson R, Peterson BK, Banks P, et al. Competitive inhibition at the glycine site of the N-methyl-D-aspartate receptor by the anesthetics xenon and isoflurane: evidence from molecular modeling and electrophysiology. Anesthesiology 2007, 107:756-767.
150. Gustavsson M, Wilson MA, Mallard C, Rousset C, Johnston MV, Hagberg H Global gene expression in the developing rat brain after hypoxic preconditioning: involvement of apoptotic mechanisms?. Pediatr Res 2007, 61:444-450.
151. Comi AM, Cho E, Mulholland JD Neural stem cells reduce brain injury after unilateral carotid ligation. Pediatr Neurol 2008, 38:86-92.
152. de Paula S, Greggio S, Dacosta JC Use of stem cells in perinatal asphyxia: from bench to bedside. J Pediatr (Rio J) 2010, 86:451-464.
153. Pimentel-Coelho PM, Magalhaes ES, Lopes LM, de Azevedo LC, Santiago MF, Mendez-Otero R Human cord blood transplantation in a neonatal rat model of hypoxic-ischemic brain damage: functional outcome related to neuroprotection in the striatum. Stem Cells Dev 2010, 19:351-358.
154. Pimentel-Coelho PM, Mendez-Otero R Cell therapy for neonatal hypoxic-ischemic encephalopathy. Stem Cells Dev 2010, 19:299-310.
155. Cotten CM, Kurtzberg J, Song H, Goldstein R, Provenzale JM Cord blood for hypoxic-ischemic encephalopathy; NCT00593242 http://clinicaltrials.gov/ct2/show/NCT00593242.